한빛사논문 | BRIC

유수종 님의 논문 목록

서울대학교 의과대학

CV File 503 kb

A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma.
- Mol. Cancer, Oct 06 2023, 22 (1) 164 | https://doi.org/10.1186/s12943-023-01872-1
- 2023-10
- 생명과학
- 한빛사논문
Differential risk of 23 site-specific incident cancers and cancer-related mortality among patients with metabolic dysfunction-associated fatty liver disease: a population-based cohort study with 9.7 million Korean subjects
- Cancer Commun., 2023 Jun 19 | https://doi.org/10.1002/cac2.12454
- 2023-06
- 의약학
- 한빛사논문
The association between alcohol consumption and the risk of hepatocellular carcinoma according to glycemic status in Korea: A nationwide population-based study
- PLoS Med., 2023 Jun 12;20(6):e1004244 | https://doi.org/10.1371/journal.pmed.1004244
- 2023-06
- 의약학
- 한빛사논문
- 유수종(서울대학교 의과대학)
Immunotherapy for hepatocellular carcinoma: Recent advances and future targets
- Pharmacol. Ther. , 2023 Apr;244:108387 | https://doi.org/10.1016/j.pharmthera.2023.108387
- 2023-04
- 의약학
- 한빛사논문
Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease
- BMC Med., Published: 04 January 2023;21;4 | https://doi.org/10.1186/s12916-022-02716-3
- 2023-01
- 의약학
- 한빛사논문
Association of fatty liver index with all-cause and disease-specific mortality: A nationwide cohort study
- Metab.-Clin. Exp., Volume 133, August 2022, 155222 | https://doi.org/10.1016/j.metabol.2022.155222
- 2022-08
- 의약학
- 한빛사논문
- 유수종(서울대학교 의과대학)
A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
- Clin Mol Hepatol, Published online: March 28, 2016, 22(1): 7-17 | DOI: https://doi.org/10.3350/cmh.2016.22.1.7
- 2016-03
- 의약학
- 상위피인용논문
- 유수종(서울대학교 의과대학, National Institutes of Health)
Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma
- J. Hepatol., Available online 9 November 2018 | https://doi.org/10.1016/j.jhep.2018.10.040
- 2018-11
- 의약학
- 한빛사논문
Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
- Hepatology, Volume 66, Issue 3, pages 855-868, September 2017 | DOI: 10.1002/hep.29237
- 2017-09
- 생명과학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기